Delirium in the ICU: time to probe the hard questions

Abstract

Prevalent in critically ill patients, delirium remains poorly understood and difficult to treat. In a cross-sectional study conducted in 12 countries, delirium was identified in close to one third of patients and was independently associated with increased mortality. While such epidemiological accounts represent an important cornerstone for research, scientific efforts are needed to elucidate the causes of delirium and the mechanisms underlying its association with poor outcomes.

Delirium affects a substantial proportion of hospitalized patients and increases their likelihood of unfavorable outcomes. This burden is especially high in critically ill populations in whom delirium is arguably the most prevalent form of organ dysfunction. In the previous issue of Critical Care, Salluh and colleagues [1] present the results of Delirium Epidemiology in Critical Care (DECCA), an international cross-sectional study evaluating the prevalence and short-term outcome of delirium in a sample of 232 patients admitted to 104 intensive care units (ICUs) across Latin America with two centers in Spain and the US. When patients were screened with the confusion assessment method for the ICU (CAM-ICU), delirium was identified in 32% of subjects and was associated with an adjusted threefold increase in ICU mortality and a greater than twofold increase in median ICU length of stay [1].

This study has the merit of evaluating delirium in a range of countries with diverse cultures and levels of economic development and across a large number of medical institutions with heterogeneous practice patterns. The DECCA results reinforce the generalizability of findings from single-center observations [2, 3] and closely match pooled prevalence and mortality estimates from a recently completed meta-analysis (RD Stevens, unpublished data). Inferences from DECCA are limited by the inability to account for pre-ICU neurological and cognitive status, the exclusion of a high proportion of potentially eligible patients because of concurrent sedation, and the absence of information on the underlying etiologies of delirium, on the treatments administered, or on the causes of death. Another limitation is that the SAPS3 (Simplified Acute Physiology Score) and SOFA (Sequential Organ Failure Assessment) scores, used here to adjust mortality risk in a multivariable model, can underestimate neurological failure indicating potential bias that would inflate adjusted odds ratios of death in delirious patients. Finally, as is the case with much delirium research, fundamental questions of nosology, mechanism, and causation are overlooked.

A central question is whether delirium, as it is currently defined [4, 5], is a satisfactory construct. The spectrum of brain dysfunction encountered in hospitalized, acutely ill patients includes significant neurobehavioral abnormalities that fall outside the scope of this definition, either because sedation or coma prevented access to the patient's mental life, a problem that was encountered in DECCA, or because delirium criteria are not met [6]. Further work is warranted to rationalize the nosology of neurobehavioral syndromes associated with critical illness.

A second issue is that the underlying neural basis of delirium remains largely speculative. Many have argued that delirium is etiologically heterogeneous and pathobiologically complex, reflecting not a unified mechanism but an array of processes such as exposure to pharmacological agents with neuromodulatory effects, the actions of pro-inflammatory signaling molecules on the brain, or changes in neurotransmitter release and reuptake [7] - suggesting considerable obstacles to mechanistic research. However, recent advances in neuroimaging, neurophysiology, and biomarker analysis suggest powerful methods that will enhance our ability to probe brain-behavior relationships in delirium and potentially identify novel therapeutic targets [8].

A third question concerns the relationship between delirium and outcomes. Why are critically ill patients with delirium at increased risk of dying, even after adjustment in multivariable models? This independent relationship with mortality, found in several recent studies [1–3, 6, 9, 10], challenges widely held concepts of delirium as a reversible 'derivative' of disorders that are more serious. Recent research indicates a link between delirium in the ICU and cognitive dysfunction in the long term [11], and these data are consistent with observations of decreased cognitive performance among long-term survivors of critical illnesses such as acute respiratory distress syndrome [12] and severe sepsis [13]. The data are also consonant with results of a large prospective cohort that found a link between hospitalization, particularly involving ICU admission, and subsequent cognitive decline and even dementia [14]. It is certain that many patients survive the ICU without developing long-lasting neurological or behavioral sequelae. Collectively, however, available studies suggest that a subset of critically ill patients are at increased risk for chronic cognitive impairments that can have a dramatic impact on functional independence and quality of life [15]. Known as an indicator of acute - and often temporary - brain dysfunction, delirium is also emerging, in selected cases, as a predictor of cognitive decline. But who are these 'selected cases'? Clearly, a research priority will be to develop tools to help answer this question.

In summary, abundant evidence indicates that delirium is a common and deadly complication of critical illness. Research must now aim to broaden knowledge on the biological mechanisms of delirium, unraveling its complex relationship to cognitive decline and mortality, with the goal of identifying effective protective and therapeutic interventions.